נאופרו 6 מ"ג / 24 שעות

País: Israel

Língua: hebraico

Origem: Ministry of Health

Ingredientes ativos:

ROTIGOTINE 6 MG / 24 HOUR

Disponível em:

CTS LTD

Código ATC:

N04BC09

Forma farmacêutica:

PATCHES

Via de administração:

TRANSDERMAL

Fabricado por:

UCB MANUFACTURING IRELAND LTD

Grupo terapêutico:

ROTIGOTINE

Indicações terapêuticas:

Neupro is indicated for the treatment of the signs and symptoms of early-stage idiopathic Parkinson's disease as monotherapy (i.e. without levodopa) or in combination with levodopa, i.e. over the course of the disease, through the late stages when the effect of levodopa wears off or becomes inconsistent and fluctuations of the therapeutic effect occur (end of dose or "on-off" fluctuations).

Data de autorização:

2012-09-01